Nonalcoholic fatty liver disease - current status and future directions.
about
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundRoles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and DiseaseMediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in miceTreatment of Obesity: Weight Loss and Bariatric Surgery.Circulating microRNAs in nonalcoholic fatty liver disease.Nuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).Mesozeaxanthin protects the liver and reduces cardio-metabolic risk factors in an insulin resistant rodent model.Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study.Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis.The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
P2860
Q26744380-DB325E03-F029-436D-B4E8-273FEEEF85E6Q26752330-C98BF90A-3CC4-4EE1-95EE-FDC9278FDFE8Q30248650-DC744E40-AA0C-4173-9F30-568D04B641B7Q35996623-78311F63-7D9C-4EFB-9D88-49955A02F95CQ36956145-3CEA86ED-C02E-447F-AD2F-B65C04991C4BQ37046260-DFDBC63D-5CC5-4631-BD78-45FE729FFC8CQ37062567-DEF4CE98-B4F1-4736-A369-856BBBBB78BBQ39170225-3FB57B57-D885-4D44-BAFF-F4F829844A80Q39519124-17450236-0821-4C43-8254-2D7CD84E3ED0Q41167222-4CE0DE5E-301E-4B76-96BA-AF1CCD91C508Q41573474-625E7814-46EA-4AFD-8453-F7880DDD9D0BQ41709332-1D707FFC-44D6-430F-9409-F3A92D541C32Q47415537-68E3073A-22D7-4C04-B1DE-2F10EB38236DQ48171878-BA407454-AFF0-4FD7-84E8-B9106EB94666Q51281926-C45C5697-3162-4E16-A387-4562082D73D5Q55035260-796783AD-117B-43B5-A3EF-F69FC976BC3DQ58726261-B1E869E6-6123-42A7-A7FF-A2F070AC72B7
P2860
Nonalcoholic fatty liver disease - current status and future directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nonalcoholic fatty liver disease - current status and future directions.
@en
type
label
Nonalcoholic fatty liver disease - current status and future directions.
@en
prefLabel
Nonalcoholic fatty liver disease - current status and future directions.
@en
P2093
P2860
P356
P1476
Nonalcoholic fatty liver disease - current status and future directions.
@en
P2093
Hans-Michael Steffen
Münevver Demir
Sonja Lang
P2860
P304
P356
10.1111/1751-2980.12291
P577
2015-09-25T00:00:00Z